TARS logo

Tarsus Pharmaceuticals (TARS) Non current assets

Annual non current assets:

$20.29M+$10.93M(+116.73%)
December 31, 2024

Summary

  • As of today (May 21, 2025), TARS annual long term assets is $20.29 million, with the most recent change of +$10.93 million (+116.73%) on December 31, 2024.
  • During the last 3 years, TARS annual non current assets has risen by +$17.33 million (+586.50%).
  • TARS annual non current assets is now at all-time high.

Performance

TARS Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

quarterly non current assets:

$19.98M-$309.00K(-1.52%)
March 31, 2025

Summary

  • As of today (May 21, 2025), TARS quarterly long term assets is $19.98 million, with the most recent change of -$309.00 thousand (-1.52%) on March 31, 2025.
  • Over the past year, TARS quarterly non current assets has increased by +$11.42 million (+133.54%).
  • TARS quarterly non current assets is now -1.52% below its all-time high of $20.29 million, reached on December 31, 2024.

Performance

TARS quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

TARS Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+116.7%+133.5%
3 y3 years+586.5%+632.3%
5 y5 years+6993.0%-

TARS Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+715.4%-1.5%+736.9%
5 y5-yearat high+6993.0%-1.5%+1416.9%
alltimeall timeat high>+9999.0%-1.5%+6885.0%

TARS Non current assets History

DateAnnualQuarterly
Mar 2025
-
$19.98M(-1.5%)
Dec 2024
$356.70M(+39.3%)
$20.29M(+5.7%)
Sep 2024
-
$19.18M(+34.6%)
Jun 2024
-
$14.26M(+66.7%)
Mar 2024
-
$8.55M(-8.6%)
Dec 2023
$256.13M(+13.6%)
$9.36M(+3.4%)
Sep 2023
-
$9.05M(+66.1%)
Jun 2023
-
$5.45M(+112.3%)
Mar 2023
-
$2.57M(+3.2%)
Dec 2022
$225.38M
$2.49M(+4.2%)
Sep 2022
-
$2.39M(-6.2%)
DateAnnualQuarterly
Jun 2022
-
$2.54M(-6.7%)
Mar 2022
-
$2.73M(-7.7%)
Dec 2021
$175.95M(+3.1%)
$2.96M(-11.1%)
Sep 2021
-
$3.32M(+30.6%)
Jun 2021
-
$2.55M(+1.7%)
Mar 2021
-
$2.50M(+90.1%)
Dec 2020
$170.66M(+194.1%)
$1.32M(-57.7%)
Sep 2020
-
$3.11M(+103.1%)
Jun 2020
-
$1.53M(+436.0%)
Dec 2019
$58.03M(+2335.2%)
$286.00K
Dec 2018
$2.38M
-

FAQ

  • What is Tarsus Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual non current assets year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly non current assets year-on-year change?

What is Tarsus Pharmaceuticals annual long term assets?

The current annual non current assets of TARS is $20.29M

What is the all time high annual non current assets for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual long term assets is $20.29M

What is Tarsus Pharmaceuticals annual non current assets year-on-year change?

Over the past year, TARS annual long term assets has changed by +$10.93M (+116.73%)

What is Tarsus Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of TARS is $19.98M

What is the all time high quarterly non current assets for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly long term assets is $20.29M

What is Tarsus Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, TARS quarterly long term assets has changed by +$11.42M (+133.54%)
On this page